SEC Form D · filed August 9, 2019
ZIOPHARM ONCOLOGY INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Murat Ozbaydar · New York, NYExecJill M. Buck · Boston, MAExecBill Sasser · Brentwood, TNDirectorHeidi M. Hagen · Boston, MADirectorBradford G. Jackson · Seattle, WAExecAravt Global LLC · New York, NYDirectorUmit Alptuna · New York, NYExecStephen J. Ketchum · New York, NYDirectorSath M. Shukla · Boston, MAExecEd Braswell · Brentwood, TNExec · DirectorEleanor M. De Groot · Boston, MAExecDawn Howe · Grand Cayman, Cayman IslandsDirectorJames D. Mitchell · Seattle, WAExecArthur N. Budge, Jr · CAMARILLO, CAExec · DirectorAli Hamed · New York, NYDirectorYieldStreet Management LLC · New York, NYDirectorRob Heyvaert · NEW YORK, NYExecKristy R. Trieste · NEW YORK, NYDirectorMark R. Kessler · New York, NYExecJason K. Mendelson · Boulder, CODirectorSath M. Shukla · Boston, MAExecHeidi M. Hagen · Boston, MADirectorEleanor M. De Groot · Boston, MAExecJill M. Buck · Boston, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗